v3.26.3
RESTATEMENT OF PREVIOUSLY ISSUED UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Tables)
6 Months Ended
Jun. 30, 2026
Accounting Changes and Error Corrections [Abstract]  
Schedule of Restatements for Previously Issued Financial Statements

The restatement had no impact on total net cash flows from operating, investing or financing activities.

 

Condensed Consolidated Balance Sheet

 

 

 

As of June 30, 2026

 

 

 

Originally Reported

 

 

Adjustment

 

 

As
Restated

 

ASSETS

 

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

 

Tekne Convertible Note Receivable

 

$

23,116,321

 

 

$

761,001

 

 

$

23,877,322

 

Total current assets

 

$

31,195,561

 

 

$

761,001

 

 

$

31,956,562

 

TOTAL ASSETS

 

$

68,361,108

 

 

$

761,001

 

 

$

69,122,109

 

LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

 

Stockholders’ Equity (Deficit)

 

 

 

 

 

 

 

 

 

Accumulated deficit

 

$

(207,415,591

)

 

$

761,001

 

 

$

(206,654,590

)

Total Stockholders’ Equity

 

$

9,369,319

 

 

$

761,001

 

 

$

10,130,320

 

TOTAL LIABILITIES, TEKNE SUBORDINATED CONVERTIBLE NOTE AND STOCKHOLDERS’ EQUITY

 

$

68,361,108

 

 

$

761,001

 

 

$

69,122,109

 

 

Condensed Consolidated Statement of Operations

 

 

 

Three Months Ended June 30, 2026

 

 

 

Originally Reported

 

 

Adjustment

 

 

As
Restated

 

Change in fair value of convertible notes receivable

 

$

288,535

 

 

$

761,001

 

 

$

1,049,536

 

Loss before provision for income taxes

 

$

(6,475,862

)

 

$

761,001

 

 

$

(5,714,861

)

Net loss

 

$

(6,475,862

)

 

$

761,001

 

 

$

(5,714,861

)

Comprehensive loss

 

$

(6,441,021

)

 

$

761,001

 

 

$

(5,680,020

)

Net loss available to common shareholders

 

$

(8,049,174

)

 

$

761,001

 

 

$

(7,288,173

)

Net loss per common share, basic and diluted (1)

 

$

(0.04

)

 

$

(1.42

)

 

$

(1.46

)

 

(1)
Net loss per common share as restated reflects the 1-for-40 reverse stock split effected on September 1, 2026, applied retroactively. Of the $(1.42) adjustment, $(1.57) is attributable to the reverse stock split and $0.15 to the correction of the error.

 

 

 

Six Months Ended June 30, 2026

 

 

 

Originally Reported

 

 

Adjustment

 

 

As
Restated

 

Change in fair value of convertible notes receivable

 

$

1,362,338

 

 

$

761,001

 

 

$

2,123,339

 

Loss before provision for income taxes

 

$

(6,935,760

)

 

$

761,001

 

 

$

(6,174,759

)

Net loss

 

$

(6,935,760

)

 

$

761,001

 

 

$

(6,174,759

)

Comprehensive loss

 

$

(6,873,592

)

 

$

761,001

 

 

$

(6,112,591

)

Net loss available to common shareholders

 

$

(8,983,130

)

 

$

761,001

 

 

$

(8,222,129

)

Net loss per common share, basic and diluted (1)

 

$

(0.06

)

 

$

(2.01

)

 

$

(2.07

)

(1)
Net loss per common share as restated reflects the 1-for-40 reverse stock split effected on September 1, 2026, applied retroactively. Of the $(2.01) adjustment, $(2.20) is attributable to the reverse stock split and $0.19 to the correction of the error.

 

Condensed Consolidated Statement of Stockholders' Equity (Deficit)

 

 

 

Three Months Ended June 30, 2026

 

 

 

Originally Reported

 

 

Adjustment

 

 

As
Restated

 

Net loss

 

$

(6,475,862

)

 

$

761,001

 

 

$

(5,714,861

)

Accumulated deficit, balance as of June 30, 2026

 

$

(207,415,591

)

 

$

761,001

 

 

$

(206,654,590

)

 

 

Condensed Consolidated Statement of Cash Flows

 

 

 

Six Months Ended June 30, 2026

 

 

 

Originally Reported

 

 

Adjustment

 

 

As
Restated

 

Net loss

 

$

(6,935,760

)

 

$

761,001

 

 

$

(6,174,759

)

Change in fair value of convertible notes receivable

 

$

(1,362,338

)

 

$

(761,001

)

 

$

(2,123,339

)